Bayer Aktiengesellschaft (BUD:BAYER)

Market Cap	17.00T +97.5%
Revenue (ttm)	17.88T -1.9%
Net Income	-77.21B
EPS	-78.59
Shares Out	n/a
PE Ratio	n/a
Forward PE	9.17
Dividend	44.63 (0.26%)
Ex-Dividend Date	Apr 28, 2025

Volume	2
Average Volume	214
Open	16,950
Previous Close	17,340
Day's Range	16,950 - 16,950
52-Week Range	7,500 - 17,940
Beta	n/a
RSI	64.62
Earnings Date	Feb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 88,502
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: BAYER

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR